Ami N. Shah, MD | Northwestern Medicine

Dr. Ami Shah, MD

Claim this profile

Northwestern University

Studies Breast Cancer
Studies Breast cancer
6 reported clinical trials
10 drugs studied

Area of expertise

1Breast Cancer
Ami Shah, MD has run 5 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
BRCA1 positive
BRCA2 positive
2Breast Cancer
Ami Shah, MD has run 3 trials for Breast cancer. Some of their research focus areas include:
Stage IV
HER2 negative
HER2 positive

Affiliated Hospitals

Image of trial facility.
Northwestern University
Image of trial facility.
Northwestern University Feinberg School Of Medicine

Clinical Trials Ami Shah, MD is currently running

Image of trial facility.

Talazoparib

for Breast Cancer

This trial is testing talazoparib, a drug that may help treat breast cancer that has spread and has specific genetic mutations (BRCA 1 or BRCA 2). Talazoparib works by stopping proteins that repair DNA, making it harder for cancer cells to survive. The goal is to see if this drug can reduce tumor size and slow down cancer growth in these patients. Talazoparib is a new treatment recently approved for use in patients with metastatic breast cancer with germline BRCA mutations.
Recruiting1 award Phase 218 criteria

More about Ami Shah, MD

Clinical Trial Related5 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Ami Shah, MD has experience with
  • Talazoparib
  • Gedatolisib
  • Belumosudil (KD025)
  • Placebo
  • Docetaxel
  • Paclitaxel
Breakdown of trials Ami Shah, MD has run
Breast Cancer
Breast cancer
Thyroid Cancer
Systemic Sclerosis
Multiple sclerosis

Other Doctors you might be interested in

Bharat B. MittalNorthwestern University
Seema Jayachandran, PhDNorthwestern University
Robert Wood, MDJohns Hopkins University School of Medicine

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ami Shah, MD specialize in?
Ami Shah, MD focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are BRCA1 positive.
Is Ami Shah, MD currently recruiting for clinical trials?
Yes, Ami Shah, MD is currently recruiting for 1 clinical trial in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Ami Shah, MD has studied deeply?
Yes, Ami Shah, MD has studied treatments such as Talazoparib, Gedatolisib, Belumosudil (KD025).
What is the best way to schedule an appointment with Ami Shah, MD?
Apply for one of the trials that Ami Shah, MD is conducting.
What is the office address of Ami Shah, MD?
The office of Ami Shah, MD is located at: Northwestern University, Chicago, Illinois 60611 United States. This is the address for their practice at the Northwestern University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security